Boehringer Ingelheim Pharma GmbH & Co.KG
About Boehringer Ingelheim Pharma GmbH & Co.KG
Categories
-
DE -
2023On CPHI since
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Products from Boehringer Ingelheim Pharma GmbH & Co.KG (1)
-
Product Mammalian Cell Cultures & Microbial Fermentation
- Fast & tailored transfers - Up- and downstream processing - Large-scale GMP facilities licensed by EMA, FDA & MHLW - Clinical and commercial supply - Launch preparation - Fill & Finish - Quality control & assurance
Boehringer Ingelheim Pharma GmbH & Co.KG Resources (2)
-
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA).
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance